These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12708456)

  • 1. Priceless goods: how should life-saving drugs be priced?
    Maitland I
    Bus Ethics Q; 2002 Oct; 12(4):451-80. PubMed ID: 12708456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
    Resnik DB
    Dev World Bioeth; 2001 May; 1(1):11-32. PubMed ID: 12870505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why life-saving drugs should be public goals.
    Kamtekar R
    Indian J Med Ethics; 2004; 1(3):77-8. PubMed ID: 16370077
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to medicines and the rhetoric of responsibility.
    Barry C; Raworth K
    Ethics Int Aff; 2002; 16(2):57-70. PubMed ID: 15709279
    [No Abstract]   [Full Text] [Related]  

  • 6. Who's in the business of saving lives?
    Lee Chang P
    J Med Philos; 2006 Oct; 31(5):465-82. PubMed ID: 17079208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The commodification of medical and health care: the moral consequences of a paradigm shift from a professional to a market ethic.
    Pellegrino ED
    J Med Philos; 1999 Jun; 24(3):243-66. PubMed ID: 10472814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.
    Faunce TA
    Monash Bioeth Rev; 2005 Jul; 24(3):10-9. PubMed ID: 16302317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 10. Intellectual property and pharmaceutical drugs: an ethical analysis.
    De George RT
    Bus Ethics Q; 2005 Oct; 15(4):549-75. PubMed ID: 16358442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 12. Some questions about the moral responsibilities of drug companies in developing countries.
    Brock DW
    Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506
    [No Abstract]   [Full Text] [Related]  

  • 13. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 14. Social responsibility and global pharmaceutical companies.
    Daniels N
    Dev World Bioeth; 2001 May; 1(1):38-41. PubMed ID: 12870507
    [No Abstract]   [Full Text] [Related]  

  • 15. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
    Sherrid P
    US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
    [No Abstract]   [Full Text] [Related]  

  • 17. Report raises questions about drug companies advertising budgets.
    AIDS Policy Law; 1999 Aug; 14(14):1, 6. PubMed ID: 11366996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: ethical responsibilities regarding drugs, patents, and health.
    Ryan MP
    Bus Ethics Q; 2005 Oct; 15(4):543-7. PubMed ID: 16358441
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmaceutical industry--to whom is it accountable?
    Holmer AF
    N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.